Expert witness

Stephen B. Levine, M.D.

Psychiatry · testified for the side defending the laws

Across a decade of reports, declarations, and deposition testimony, Levine consistently argues that most childhood gender dysphoria resolves without medical intervention if children are not socially or medically transitioned, and that psychotherapy exploring underlying causes (trauma, family dynamics, autism, other comorbidities) should precede any physical intervention. He characterizes the evidence base for pediatric puberty blockers, cross-sex hormones, and surgery as low quality, citing the Cochrane Library, NICE evidence reviews, and the Cass Review, and argues that WPATH's Standards of Care reflect advocacy as much as science, a shift he traces to his own 2002 resignation from the organization he once helped lead. In prison litigation (2015-2017) he framed sex reassignment surgery as always elective, never medically urgent, and sometimes an adaptive response to incarceration rather than a fixed identity, testimony courts have criticized as unsupported and, in one instance, resting on a fabricated anecdote. In later youth-care litigation (2020-2023) he maintains that transition is experimental and unproven for minors while repeatedly declining to say treatment is 'never' appropriate, and his deposition testimony shows he personally continues to write authorization letters for hormone therapy and gender-affirming surgery for some adult patients.

Cases and documents

The documents are listed as the archive holds them. A document labeled with its kind alone, such as "Expert report", is one the archive attributes to the expert. One labeled "Mentions or contains" names the expert or includes the expert's testimony, and is not attributed to the expert.

B.P.J. v. West Virginia State Board of Education U.S. Supreme Court · 2023

Dekker v. Weida 11th Cir. · 2026

  • Expert report: Exhibit Ex 12 Dr. Levine Expert Report In the case's documents
  • Trial testimony: PLAINTIFFS' MOTION TO EXCLUDE EXPERT TESTIMONY OF STEPHEN B. LEVINE, M.D Open(opens another site) · In the case's documents
  • Trial testimony: PLAINTIFFS' MEMORANDUM OF LAW IN SUPPORT OF MOTION TO EXCLUDE EXPERT TESTIMONY OF STEPHEN B. LEVINE, M.D Open(opens another site) · In the case's documents
    19 attachments
    1. Affidavit Declaration of Carl S. Charles
    2. Exhibit Exhibit A-Expert Witness Report of Stephen B. Levine, M.D.
    3. Exhibit Exhibit B- Brandt Trial Testimony
    4. Exhibit Exhibit C- Fain Deposition Transcript
    5. Exhibit Exhibit D-Kadel Deposition Transcript
    6. Exhibit Exhibit E- Soneeya Trial Transcript
    7. Exhibit Exhibit F-Claire Deposition Transcript
    8. Exhibit Exhibit G- Dahlen 2021 Article
    9. Exhibit Exhibit H- Cass Review About Page
    10. Exhibit Exhibit I- Endocrine Society Guideline 2017
    11. Exhibit Exhibit J-WPATH SOC 8
    12. Exhibit Exhibit K-Olsen Kennedy Expert Report
    13. Exhibit Exhibit L-Dhejne Study 2011
    14. Exhibit Exhibit M-Dhejne Thesis
    15. Exhibit Exhibit N- DSM 5
    16. Exhibit Exhibit O-Correction to Littman 2018
    17. Exhibit Exhibit P-ROGD Clinical Study
    18. Exhibit Exhibit Q- Rebuttal Report of Stephen B. Levine M.D.
    19. Exhibit Exhibit R- BPJ Deposition Transcript
  • Expert report: Exhibit Exhibit Q- Rebuttal Report of Stephen B. Levine M.D Open(opens another site) · In the case's documents
  • Expert report: Exhibit Exhibit A-Expert Witness Report of Stephen B. Levine, M.D In the case's documents
  • Deposition: Exhibit 83 - Deposition of Stephen Levine, B.P.J. v. W. VA, 2:21-CV-00316 (W.D Open(opens another site) · In the case's documents
16 more documents
  • Deposition: Exhibit 85 - Deposition of Stephen Levine, Claire v. D.M.S., 4:20-cv-00020 (N.D Open(opens another site) · In the case's documents
  • Deposition: Exhibit 86 - Deposition of Stephen Levine, Fain v. Crouch, 3:20-cv-00740 (S.D. W Open(opens another site) · In the case's documents
  • Deposition: Exhibit 87 - Deposition of Stephen Levine, Kadel v. Folwell, 1:19-cv-272 (M.D. N Open(opens another site) · In the case's documents
  • Declaration: Exhibit 275 - Email exchange between Andrew Sheeran and Romina Brignardello Pete Open(opens another site) · In the case's documents
  • Mentions or contains: deposition: Affidavit Declaration of Carl S. Charles Open(opens another site) · In the case's documents
  • Mentions or contains: deposition: PLAINTIFFS' RULE 26(a)(3) PRETRIAL DISCLOSURES Open(opens another site) · In the case's documents
  • Mentions or contains: deposition: AMENDED DOCUMENT by AUGUST DEKKER, JANE DOE, JOHN DOE, SUSAN DOE, K F, JADE LADUE, BRIT ROTHSTEIN. Amendment to 162 Rule 26 Disclosures Open(opens another site) · In the case's documents
  • Mentions or contains: deposition: Exhibit List (Notice of Filing, Part 2 of 10) Open(opens another site) · In the case's documents
    40 attachments
    1. Exhibit 41 - LGBT Health Disparities Policy, ACOP
    2. Exhibit 42 - AMA Letter to Natl Gov. Assoc. (April 26, 2021)
    3. Exhibit 43 - AMA/GLMA Issue Brief on health insurance coverage for gender-affirming care
    4. Exhibit 44 - AMA Resolution H-185.950
    5. Exhibit 45 - APA, Guidelines for Psychological Practice with Transgender and Gender Non-conforming People
    6. Exhibit 46 - APA Resolution on Gender Identity Change Efforts (Feb. 2021)
    7. Exhibit 47 - APA Position Statement Trans and Gender Diverse Youth (July 2020)
    8. Exhibit 48 - APA Position Statement on Access to Care (July 2018)
    9. Exhibit 49 - Endocrine Society Transgender Health Position Statement
    10. Exhibit 50 - Pediatric Endocrine Society Opposition to Bills that Harm Transgender Youth (April 2021)
    11. Exhibit 51 - SAHM Statement in Opposition of State Legislation Barring Evidence Based Treatment
    12. Exhibit 52 - WMA Statement on Transgender People (Oct. 2015)
    13. Exhibit 53 - Van Meter Pediatric Endocrinology Excerpt
    14. Exhibit 54 - Humana Pharmacy Coverage Policy, commercial insurance coverage policy for testosterone 5/18/2022
    15. Exhibit 55 - Aetna Clinical Policy Bulletin, coverage of Progestins 4/27/2023
    16. Exhibit 56 - Aetna, Clinical Policy Bulletin, gender affirming surgery 6/22/2023
    17. Exhibit 57 - Aetna, Clinical Policy Bulletin, GnRHa 2/23/2023
    18. Exhibit 58 - Humana, Medical Coverage Policy, cover of gender affirmation surgery 9/22/2022
    19. Exhibit 59 - Molina Healthcare, Coverage criteria for Gender Dysphoria Hormone Therapy July 2023
    20. Exhibit 60 - Molina Clinical Policy, Gender Affirmation Treatment and Procedures (Marketplace) - 2/8/2023
    21. Exhibit 61 - UHC Gender Dysphoria Treatment (commercial), 4/1/2023
    22. Exhibit 62 - Ctrs. for Medicare & Medicaid Servs., EPSDT A Guide for States: Coverage in the Medicaid Benefit for Children and Adolescents
    23. Exhibit 63 - Ctrs. for Medicare & Medicaid Servs., CMCS Informational Bulletin (July 21, 2022)
    24. Exhibit 64 - Ctrs. for Medicare & Medicaid Servs., Decision Memo for Gender Dysphoria and Surgery (Aug. 20, 2016)
    25. Exhibit 65 - Office of the Press Secretary, Presidential Memo (Aug. 25, 2017)
    26. Exhibit 66 - FDA, Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products (Draft Guidance) (2018)
    27. Exhibit 67 - FDA, Understanding Unapproved Use of Approved Drugs "Off Label," (2018)
    28. Exhibit 68 - U.S. Drug Enforcement Administration, Drug Scheduling, July 10, 2018
    29. Exhibit 69 - U.S. Comm. on Civil Rights Statement on State Laws Targeting LGBTQ Community, (April 18, 2016)
    30. Exhibit 70 - U.S. Comm. on Civil Rights Statement on Military Ban (Aug. 18, 2017)
    31. Exhibit 71 - Dept of Health & Human Servs., Departmental Appeals Bd., Appellate Div., Decision No. 2576 (May 30, 2014)
    32. Exhibit 72 - OASH, Gender-Affirming Care and Young People
    33. Exhibit 73 - SAMHSA, Ending Conversion Therapy (Oct. 2015)
    34. Exhibit 74 - SAMHSA, Moving Beyond Change Efforts (2023)
    35. Exhibit 75 - NCTSN, Gender-Affirming Care is Trauma-Informed Care
    36. Exhibit 76 - U.S. Presidential Proclamation, Transgender Day of Visibility, 2022
    37. Exhibit 77 - U.S. Presidential Proclamation, Transgender Day of Visibility, 2023
    38. Exhibit 78 - Executive Order, Preventing and Combating Discrimination on the Basis of Gender Identity or Sexual Orientation (Jan. 20, 2021)
    39. Exhibit 79 - Medicaid Coverage for Gender-Affirming Care, Williams Institute (Dec. 2022)
    40. Exhibit 80 - Excerpts from trial transcript Vol. 5 (Levine), Brandt v. Rutledge, 4:21-CV-00450-JM (E.D. Ark.)
  • Mentions or contains: deposition: Exhibit List (Notice of Filing, Part 4 of 10) Open(opens another site) · In the case's documents
    40 attachments
    1. Exhibit 121 - On Gender Dysphoria, 2017 Dhejne
    2. Exhibit 122 - Long-Term Follow-up of Transsexual Persons Undergoing Sex Reassignment Surgery, 2011 Dhejne
    3. Exhibit 123 - Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons, 2017 Hembree et al.
    4. Exhibit 124 - Interrogating Gender-Exploratory Therapy, 2023 Ashley
    5. Exhibit 125 - Transgender Surgery & Christian Anthropology, Presentation by Patrick W. Lappert
    6. Exhibit 126 - What is Psychiatry, American Psychiatric Association
    7. Exhibit 127 - Lewiss Child and Adolescent Psychiatry, Fifth Edition, 2018
    8. Exhibit 128 - Memo Outlining Evidence for Change for Gender Identity Disorder in the DSM-5, 2013 Zucker, et al.
    9. Exhibit 129 - A Developmental, Biopsychosocial Model for the Treatment of Children with Gender Identity Disorder, 2012 Zucker
    10. Exhibit 130 - APA Statement on Zucker (2008)
    11. Exhibit 131 - Working for Inclusion: Time for Congress to Enact Federal Legislation to Address Workplace Discrimination Against Lesbian, Gay, Bisexual, and Transgender Americans, Briefing Report
    12. Exhibit 132 - Position Statement on Conversion Therapy, APA (Dec. 2018)
    13. Exhibit 133 - Do Clinical Data from Transgender Adolescents Support the Phenomenon of Rapid Onset Gender Dysphoria, 2022 Bauer et al.
    14. Exhibit 134 - American Society of Plastic Surgeons, State Focus on Gender Affirmation Intensifies, Feb. 25, 2021,
    15. Exhibit 135 - Plastic surgeon: Sex-change operation utterly unacceptable and a form of child abuse, Sept. 9, 2019,
    16. Exhibit 136 - Transphobic tweets linked to Oxford sociology professor, The Oxford Student (Oct. 26, 2018)
    17. Exhibit 137 - Long-term outcomes of the treatment of central precocious puberty, 2016 Guaraldi, et al.
    18. Exhibit 138 - Fertility of Women Treated during Childhood with Triptorelin (Depot Formulation) for Central Precocious Puberty, 2021 Martinerie, et al.
    19. Exhibit 139 - Gender dysphoria in childhood, 2016 Ristori & Steensman
    20. Exhibit 140 - Gender Identity 5 Years After Social Transition, 2022 Olson et al.
    21. Exhibit 141 - Puberty Suppression in Adolescents With Gender Identity Disorder, 2011 de Vries, et al.
    22. Exhibit 142 - Understanding the Well-Being of LGBTQI+ Populations, 2020 Natl Academies of Sciences, Engineering, and Medicine
    23. Exhibit 143 - The Health of Lesbian, Gay, Bisexual and Transgender People, 2011 Natl Academies of Sciences, Engineering, and Medicine
    24. Exhibit 144 - The Right to the Best Care for Children Does Not Include the Right to Medical Transition, 2019 Laidlaw, et al.
    25. Exhibit 145 - Strangers in a Strange Land, 2020 Donovan & Sotomayor
    26. Exhibit 146 - Effect of antidepressant medications on semen parameters and male fertility, 2020 Beeder & Samplaski
    27. Exhibit 147 - The effect of antidepressants on fertility, 2016 Casilla-Lennon, et al.
    28. Exhibit 148 - Trends in Gender-affirming Surgery in Insured Patients in the U.S., 2018 Lane et al.
    29. Exhibit 149 - Gender-Affirming Treatment of Gender Dysphoria in Youth, 2022 Clayton et al.
    30. Exhibit 150 - AAP News, Risk of Pseudotumor Cerebri added to Labeling for Gonadotropin-Releasing Hormone Agonists, (2022)
    31. Exhibit 151 - Longitudinal Impact of Gender-Affirming Endocrine Intervention on the Mental Health and Well-Being of Transgender Youths, 2020 Achille et al.
    32. Exhibit 152 - Long-Term Effect of Gender-Affirming Hormone Treatment on Depression and Anxiety Symptoms in Transgender People, 2020 Aldridge et al.
    33. Exhibit 153 - Off-Label Medication use in Children, More Common than We Think: A Systematic Review of the Literature, 2018 Allen et al.
    34. Exhibit 154 - Association Between Gender-Affirming Surgeries and Mental Health Outcomes, 2021 Almazan et al.
    35. Exhibit 155 - Top Surgery and Chest Dysphoria Among Transmasculine and Nonbinary Adolescents and Young Adults, 2022 Ascha et al.
    36. Exhibit 156 - Hormone Therapy, Mental Health, and Quality of Life Among Transgender People: A Systematic Review, 2021 Baker et al.
    37. Exhibit 157 - GRADE Guidelines: 3 Rating the Quality of Evidence, 2011 Balshem et al.
    38. Exhibit 158 - Harry Benjamin, The Transsexual Phenomenon (1966)
    39. Exhibit 159 - Anabolic Steroid Abuse and Dependence, 2002 Brower et al.
    40. Exhibit 160 - Transgender and Gender-Nonbinary Patient Satisfaction after Transmasculine Chest Surgery, 2021 Bustos et al.
  • Mentions or contains: deposition: Exhibit List (Notice of Filing, Part 5 of 10) Open(opens another site) · In the case's documents
    40 attachments
    1. Exhibit 161 - Regret after Gender-affirmation Surgery: A Systematic Review and Metaanalysis of Prevalence, 2021 Bustos et al.
    2. Exhibit 162 - Effects of Long-Term Exogenous Testosterone Administration on Ovarian Morphology, Determined by Transvaginal (3D) Ultrasound in Female-to-Male Transsexuals, 2017 Caanen et al.
    3. Exhibit 163 - Short-term Outcomes of Pubertal Suppression in a Selected Cohort of 12 to 15 Year Old Young People with Persistent Gender Dysphoria in the UK, 2021 Carmichael at al.
    4. Exhibit 164 - Psychosocial Functioning in Transgender Youth after 2 Years of Hormones, 2023 Chen et al.
    5. Exhibit 165 - Pubertal Delay as an Aid in Diagnosis and Treatment of a Transsexual Adolescent, 1998 Cohen-Kettenis & van Goozen
    6. Exhibit 166 - Hormonal Treatment Reduces Psychobiological Distress in Gender Identity Disorder, Independently of the Attachment Style, 2013 Colizzi et al.
    7. Exhibit 167 - Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria, 2015 Costa et al.
    8. Exhibit 168 - Young Adult Psychological Outcome After Puberty Suppression and Gender Reassignment, 2014 de Vries et al.
    9. Exhibit 169 - An Analysis of All Applications for Sex Reassignment Surgery in Sweden, 1960-2010: Prevalence, Incidence, and Regrets, 2014 Dhejne et al.
    10. Exhibit 170 - Gender Nonconforming Youth: Current Perspectives, 2017 Ehrensaft
    11. Exhibit 171 - What makes clinical research ethical?, 2000 Emanuel et al.
    12. Exhibit 172 - Treatment of Central Precocious Puberty, 2019 Eugster
    13. Exhibit 173 - Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data, 2016 Fisher et al.
    14. Exhibit 174 - Chest Surgery in Female to Male Transgender Individuals, 2017 Frederick et al.
    15. Exhibit 175 - Off-Label Use of Drugs in Children, 2014 Galinkin et al.
    16. Exhibit 176 - Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth, 2022 Green
    17. Exhibit 177 - Feminizing Genital Gender-Confirmation Surgery, 2018 Hadj-Moussa et al.
    18. Exhibit 178 - Satisfaction with Male-to-Female Gender Reassignment Surgery, 2014 Hess et al.
    19. Exhibit 179 - Effects of Different Steps in Gender Reassignment Therapy on Psychopathology, 2014 Heylens, et al.
    20. Exhibit 180 - Supporting Sexuality and Improving Sexual Function in Transgender Persons, 2019 Holmberg et al.
    21. Exhibit 181 - Outcome of Vaginoplasty in Male-to-Female Transgenders: A Systematic Review of Surgical Techniques, 2015 Horbach et al.
    22. Exhibit 182 - The Quality of Evidence for Medical Interventions Does Not Improve or Worsen: A Metaepidemiological Study of Cochrane Reviews, 2020 Howick et al.
    23. Exhibit 183 - Testosterone Treatment and MMPI2 Improvement in Transgender Men, 2015 Keo-Meier et al.
    24. Exhibit 184 - Bone Mass in Young Adulthood Following Gonadotropin-Releasing Hormone Analog Treatment and Cross-Sex Hormone Treatment in Adolescents with Gender Dysphoria, 2015 Klink et al.
    25. Exhibit 185 - Fertility Options in Transgender and Gender Diverse Adolescents, 2017 Knudson & De Sutter
    26. Exhibit 186 - Australian Children and Adolescents with Gender Dysphoria, 2021 Kozlowska et al.
    27. Exhibit 187 - Body Dissatisfaction and Mental Health Outcomes of Youth on Gender-Affirming Hormone Therapy, 2020 Kuper et al.
    28. Exhibit 188 - Transgender Men Who Experienced Pregnancy After Female-to-Male Gender Transitioning, 2014 Light, et al.
    29. Exhibit 189 - Psychosocial Assessment in Transgender Adolescents, 2020 Lopez de Lara.
    30. Exhibit 190 - Christy Mallory et al., Conversion Therapy and LGBT Youth 2 (2019 ed.)
    31. Exhibit 191 - Successful Oocyte Cryopreservation Using Letrozole as an Adjunct to Stimulation in a Transgender Adolescent after GnRH Agonist Suppression, 2021 Martin et al.
    32. Exhibit 192 - Experience of Chest Dysphoria and Masculinizing Chest Surgery in Transmasculine Youth, 2021 Mehringer et al.
    33. Exhibit 193 - Breast Augmentation in Male-to-Female Transgender Patients: Technical Considerations and Outcomes, 2019 Miller et al.
    34. Exhibit 194 - Guiding the ConversationTypes of Regret after Gender-Affirming Surgery and Their Associated Etiologies, 2021 Narayan et al.
    35. Exhibit 195 - Individual Treatment Progress Predicts Satisfaction with Transition-Related Care for Youth with Gender Dysphoria, 2021 Nieder et al.
    36. Exhibit 196 - Sexual Experiences in Transgender People, 2018 Nikkelen & Baudewijntje.
    37. Exhibit 197 - Quality of Life of Treatment-Seeking Transgender Adults, 2018 Nobili et al.
    38. Exhibit 198 - Chest Reconstruction and Chest Dysphoria in Transmasculine Minors and Young Adults: Comparisons of Nonsurgical and Postsurgical Cohorts, 2018 Olson-Kennedy et al.
    39. Exhibit 199 - Mental Health of Transgender Children Who Are Supported in Their Identities, 2016 Olson, et al.
    40. Exhibit 200 - Association Between Gender Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction, and Mental Health in a Cohort of Transgender Individuals, 2018 Owen-Smith, et al.
  • Mentions or contains: deposition: Exhibit List (Notice of Filing, Part 7 of 10) Open(opens another site) · In the case's documents
    40 attachments
    1. Exhibit 237A - (Placeholder) Dekker medical records
    2. Exhibit 238 - GAPMS Decision Tree Checklist
    3. Exhibit 239 - GAPMS GnRH for treatment of gender dysphoria
    4. Exhibit 240 - GAPMS GnRH for treatment of gender dysphoria
    5. Exhibit 241 - GAPMS Cross Sex Hormone Therapy 5/20/2022
    6. Exhibit 242 - GAPMS Cross Sex Hormone Therapy Report (edited) - 5/20/2022
    7. Exhibit 243 - GAPMS Cross Sex Hormone Therapy 11/2/2016
    8. Exhibit 244 - GAPMS Gender Confirmation Surgery (incomplete) 7/19/2017
    9. Exhibit 245 - DUR Meeting Transcript 9/26/2015
    10. Exhibit 246 - DUR Quarterly Report - 2015
    11. Exhibit 247 - DUR Meeting Minutes 1/16/2016
    12. Exhibit 248 - DUR Meeting Minutes 9/24/2016
    13. Exhibit 249 - Pharmacy log 5/31/2016
    14. Exhibit 250 - AHCA review of research 7/25/2016
    15. Exhibit 251 - AHCA review of state practice 8/17/2016
    16. Exhibit 252 - Arlene Elliot research regarding Medicaid coverage of care in other states July 27, 2016
    17. Exhibit 252A - Arlene Elliot research regarding Medicaid coverage of care in other states July 27, 2016
    18. Exhibit 252B - Arlene Elliot research regarding Medicaid coverage of care in other states July 27, 2016
    19. Exhibit 252C - Arlene Elliot research regarding Medicaid coverage of care in other states July 27, 2016
    20. Exhibit 253 - Aetna clinical criteria for cross-sex hormone therapy 8/18/2016
    21. Exhibit 254 - Arlene Elliot email re GnRH coverage 8/29/2016
    22. Exhibit 255 - Rebecca Borgert email regarding Endocrine Society guidelines 8/29/2016
    23. Exhibit 256 - AHCA GAPMS routing and tracking form for puberty suppression therapy 8/31/2016
    24. Exhibit 257 - Special services criteria re GnRH coverage 9/20/2016 (updated 11/17/17)
    25. Exhibit 258 - AHCA letter to Childrens Medical Services re drug criteria and coverage 10/6/2016
    26. Exhibit 259 - AHCA tracking form for GAPMS research re puberty suppression 9/26/2016
    27. Exhibit 260 - AHCA GAPMS routing and tracking form for cross-sex hormone therapy 11/2/2016
    28. Exhibit 261 - FL House letter to AHCA re drug treatment for gender dysphoria 11/22/2016
    29. Exhibit 262 - DUR transcript 3/23/2017
    30. Exhibit 263 - Draft GAPMS re gender-affirming surgery 7/19/2017
    31. Exhibit 264 - Email exchange re Medicaid coverage of gender affirming surgery June 2018
    32. Exhibit 264A - Email exchange re Medicaid coverage of gender affirming surgery June 2018
    33. Exhibit 265 - AHCA routing form tracking response to MCO question about Medicaid coverage of surgery June 2018
    34. Exhibit 266 - AHCA document closing the project re responding to MCO question about Medicaid coverage of surgery June 2018
    35. Exhibit 267 - Email from Theresa Kumar to Jesse Botcher 10/18/2019
    36. Exhibit 268 - Email from DD Pickle to Krisin Sokoloski 1/5/2022
    37. Exhibit 269 - AHCA approval of Simply Healthcares provider manual 3/24/2022
    38. Exhibit 269A - AHCA approval of Simply Healthcares provider manual 3/24/2022
    39. Exhibit 269B - AHCA approval of Simply Healthcares provider manual 3/24/2022
    40. Exhibit 269C - AHCA approval of Simply Healthcares provider manual 3/24/2022
  • Mentions or contains: deposition: Exhibit List (Notice of Filing, Part 8 of 10) Open(opens another site) · In the case's documents
    40 attachments
    1. Exhibit 270 - Email re commercial plan coverage 3/24/2022
    2. Exhibit 271 - Communication from Peter Ring re procedures billed to treat gender dysphoria 4/7/2022
    3. Exhibit 272 - Email from Andy Bardos to Andrew Sheeran re Cantor and legal research 4/11/2022
    4. Exhibit 273 - Email forwarded by Andrew Sheeran from Ashley Lukis scheduling a call with James Cantor 4/13/2022
    5. Exhibit 274 - Email from Andrew Sheeran to Miriam Grossman 4/14/2022
    6. Exhibit 275 - Email exchange between Andrew Sheeran and Romina Brignardello Petersen 4/18/2022
    7. Exhibit 276 - Email from Susan Williams to Shantrice Green re GAPMS on cross-sex hormone therapy 4/20/2022
    8. Exhibit 277 - Email from Amy Zitiello to Vern Hamilton regarding FDOH guidance 4/20/2022
    9. Exhibit 277A - Email from Amy Zitiello to Vern Hamilton regarding FDOH guidance 4/20/2022
    10. Exhibit 278 - Email from Cody Farill regarding data from Magellan about drug coverage - 4/20/2022
    11. Exhibit 279 - Communication between Jason Weida and Dr. Michelle Cretella 4/21/2025
    12. Exhibit 280 - Communication between Romina Brignardello-Petersen and Jason Weida regarding types of surgeries on which to focus 4/25/2022
    13. Exhibit 281 - Communication between Jason Weida and Vern Hamilton regarding planned response to Dr. Zitiellos question about FDOH guidance 4/29/2022
    14. Exhibit 282 - Draft GAPMS on gender affirming surgery (with handwritten notes) - May 2022
    15. Exhibit 283 - Jason Weida communication regarding report from Romina Brignardello-Petersen 5/5/2022
    16. Exhibit 283A - Jason Weida communication regarding report from Romina Brignardello-Petersen 5/5/2022
    17. Exhibit 283B - Jason Weida communication regarding report from Romina Brignardello-Petersen 5/5/2022
    18. Exhibit 283C - Jason Weida communication regarding report from Romina Brignardello-Petersen 5/5/2022
    19. Exhibit 283D - Jason Weida communication regarding report from Romina Brignardello-Petersen 5/5/2022
    20. Exhibit 283E - Jason Weida communication regarding report from Romina Brignardello-Petersen 5/5/2022
    21. Exhibit 284 - Jason Weida communication regarding articles provided to him by Dr. Van Mol 5/6/2022
    22. Exhibit 285 - Dr. Van Mol communication with Jason Weida and Matthew Brackett about gender affirming care 5/7/022
    23. Exhibit 286 - Dr. Van Mols edits to June 2022 GAPMS memo 5/13/2022
    24. Exhibit 286A - Dr. Van Mols edits to June 2022 GAPMS memo 5/13/2022
    25. Exhibit 286B - Dr. Van Mols edits to June 2022 GAPMS memo 5/13/2022
    26. Exhibit 287 - Text message from Jason Weida regarding Eknes-Tucker and James Cantor 5/17/2022
    27. Exhibit 288 - Email from Shantrice Green to Susan Williams and Kelly Rubin regarding the GAPMS memo on cross-sex hormone therapy 5/20/2022
    28. Exhibit 289 - Draft of GAPMS cross-sex hormone therapy memo 5/20/2022
    29. Exhibit 290 - Jason Weida asks Dr. Van Mol for assistance locating specific witnesses 5/21/2022
    30. Exhibit 291 - Email between Dr. Van Mol and Jason Weida regarding reimbursement 5/21/2022
    31. Exhibit 292 - Invoices from Romina Brignardello-Petersen 5/24/2022
    32. Exhibit 292A - Invoices from Romina Brignardello-Petersen 5/24/2022
    33. Exhibit 293 - Template denial for requesting rule workshop June 2022
    34. Exhibit 294 - Projected Rulemaking Timeline June 2022
    35. Exhibit 295 - Gender Dysphoria/Transgender Health Care Non-Legislative Pathway June 2022
    36. Exhibit 296 - Gender Dysphoria/Transgender Health Care Policy Pathway June 2022
    37. Exhibit 297 - AHCA GAPMS routing and tracking form for June 2022 GAPMS 6/1/2022
    38. Exhibit 297A - AHCA GAPMS routing and tracking form for June 2022 GAPMS 6/1/2022
    39. Exhibit 298 - Communication between Ashley Peterson and Jason Weida regarding an inventory of gender affirming care 6/3/2022
    40. Exhibit 298A - Communication between Ashley Peterson and Jason Weida regarding an inventory of gender affirming care 6/3/2022
  • Mentions or contains: deposition: Exhibit List (Notice of Filing, Part 9 of 10) Open(opens another site) · In the case's documents
    40 attachments
    1. Exhibit 299 - (Redacted) Email communication between AHCA and Magellan regarding coverage of GnRH to treat gender dysphoria
    2. Exhibit 300 - AHCA communication regarding the Special Services Criteria for puberty blockers 6/10/2022
    3. Exhibit 301 - Communication between Jason Weida and Dr. Van Mol about a witness for the July 8th hearing 6/14/2022
    4. Exhibit 302 - Email communication between Dr. Christopher Cogle and Jeffrey English 6/27/2022
    5. Exhibit 303 - Communication regarding meeting between Miriam Grossman, Dr. Van Mol, Jason Weida, Andrew Sheeran, and Holtzman Vogel regarding July 8th hearing 6/30/2022
    6. Exhibit 304 - Communication between Dr. Van Mol and AHCA - 7/2/2022
    7. Exhibit 305 - Brief of the July 8th rule hearing 7/8/2022
    8. Exhibit 306 - Transcript from July 8th rule hearing 7/8/2022
    9. Exhibit 307 - Email from Miriam Grossman 7/10/2022
    10. Exhibit 308 - Email communications with Jason Weida and Dr. Van Mol 7/14/2022
    11. Exhibit 309 - Communications regarding AHCAs development of public comment binder provided to the consultants 7/19/2022
    12. Exhibit 310 - Invoice from Dr. Van Meter 8/4/2022
    13. Exhibit 311 - Communication to Jason Weida regarding witnesses for a hearing 8/10/2022
    14. Exhibit 312 - Invoices from Dr. Van Mol 8/11/2022
    15. Exhibit 313 - Email communications regarding implementation of 59G-1.050(7) - 8/22/2022
    16. Exhibit 313A - Email communications regarding implementation of 59G-1.050(7) - 8/22/2022
    17. Exhibit 314 - Communication between AHCA and EOG regarding planned communications about June 2022 GAPMS and 59G-1.050(7) - 8/22/2022
    18. Exhibit 315 - SMMC Policy Transmittal draft regarding non-coverage of gender dysphoria treatments August 22, 2022
    19. Exhibit 316 - AHCA Medicaid Health Care Alert regarding prohibition on coverage for gender affirming care
    20. Exhibit 317 - AHCA draft response to media regarding gender affirming care 9/1/2022
    21. Exhibit 318 - List of appeals for denials of hormone therapy 12/19/2022
    22. Exhibit 319 - List of requests for surgery to treat gender dysphoria 12/19/2022
    23. Exhibit 320 - AHCA After the Fact Request form for Quentin Van Meter 6/13/2022
    24. Exhibit 321 - AHCA After the Fact Request form for Andre Van Mol 5/26/2022
    25. Exhibit 322 - Draft of welcome/opening remarks for July 8th rule hearing
    26. Exhibit 323 - Endocrine Society public comment
    27. Exhibit 324 - Yale public comment
    28. Exhibit 325 - American Academy of Pediatrics public comment
    29. Exhibit 326 - Florida Medicaid, Comment Summary for Rule 59G-1.050 (20 pages)
    30. Exhibit 327 - Florida Medicaid, Comment Summary for Rule 59G-1.050 (17 pages)
    31. Exhibit 328 - Email communication between Van Mol and Weida and attachment
    32. Exhibit 328A - Email communication between Van Mol and Weida and attachment
    33. Exhibit 329 - Florida Medicaid & G/TAT, Andrea Van Mol May 2022
    34. Exhibit 330 - GAPMS Specially Modified Foods
    35. Exhibit 331 - GAPMS Scleral Contact Lenses
    36. Exhibit 332 - GAPMS Fractional Exhaled Nitric Oxide
    37. Exhibit 333 - GAPMS Breast Pump
    38. Exhibit 334 - Email from Miriam Grossman July 7, 2022
    39. Exhibit 335 - Proposed media response from Brock Juarez to Taryn Fenske 8/29/2022
    40. Exhibit 336 - Order striking Van Meter
  • Mentions or contains: deposition: Exhibit List (Notice of Filing, Part 10 of 10) Open(opens another site) · In the case's documents
    21 attachments
    1. Exhibit 337 - Email communication between Van Meter and AHCA Counsel
    2. Exhibit 338 - AHCA Microsoft Teams Meeting Invite
    3. Exhibit 339 - Email communication between Van Meter and Jason Weida
    4. Exhibit 340 - AHCA Van Meter Invoice
    5. Exhibit 341 - HCA Hearing on General Medicaid Policy
    6. Exhibit 342 - Email communication between Devona Pickle and Van Meter
    7. Exhibit 343 - Email communication between consultants, counsel, and Van Meter
    8. Exhibit 344 - AHCA Teams Meeting Invites
    9. Exhibit 344A - AHCA Teams Meeting Invites
    10. Exhibit 345 - Email communication between AHCA and consultants
    11. Exhibit 346 - Email communication between Sheeran and Brignardello-Petersen
    12. Exhibit 347 - Email communication between Van Mol and Weida
    13. Exhibit 348 - Van Mol comments to Alstott letter
    14. Exhibit 349 - Email communication between Weida Van Meter, Van Mol and Grossman
    15. Exhibit 350 - Email communication between Cantor and Weida
    16. Exhibit 351 - Sex Differences in Verbal Fluency during Adolescence, 2013 Soleman
    17. Exhibit 352 - Oestrogens are Not Related to Emotional Processing, Soleman 2016
    18. Exhibit 353 - Puberty suppression and executive functioning, 2015 Staphorsius
    19. Exhibit 354 - Alterations in the inferior fronto-occipital fasciculus, van Heesewijk
    20. Exhibit 355 - Spreadsheet summarizing Florida Medicaid coverage
    21. Exhibit 356 - DOJ, Dear State Attorneys General Letter re Transgender Youth (March 31, 2022)
  • Mentions or contains: deposition: PRETRIAL Stipulation Open(opens another site) · In the case's documents
  • Mentions or contains: deposition: Appendix 3 - Plaintiffs' Amended Exhibit List Open(opens another site) · In the case's documents

Doe v. Ladapo N.D. Fla. · 2024

Hennessy-Waller v. Snyder D. Ariz. · 2021

January Littlejohn v. School Board of Leon County Florida 11th Cir. · 2023

  • Mentions or contains: affidavit: Amicus Brief filed by Amicus Curiae Doctor Erica E. Anderson, Ph.D.. Service date: 06/20/2023 email - Attorney for Amici Curiae: Berg, Clark, Esenberg, Estrada, Fitschen, Kniffin, Lawkowski, Sandefur, Sarelson, Shapiro,… Open(opens another site) · In the case's documents

John and Jane Parents 1 v. Montgomery County Board of Education 4th Cir. · 2022

Keohane v. Jones N.D. Fla. · 2021

L.E. v. Lee M.D. Tenn. · 2024

Lindsay Hecox v. Bradley Little 9th Cir. · 2020

Maxwell Kadel v. Dale Folwell 4th Cir. · 2022

3 more documents

Michelle-Lael Norsworthy v. Jeffrey Beard 9th Cir. · 2015

Shauntae Anderson v. William Crouch 4th Cir. · 2023

How courts have treated their testimony

Each ruling that discusses their testimony, by what it did for the side that called them. The counts are the profile's own, for the rulings it lists.

Helped the side that called them: 3Credited against the side that called them: 5Discounted, criticized or limited: 6Neither: 7
Helped the side that called them: 3Credited against the side that called them: 5Discounted, criticized or limited: 6Neither: 7
2012

Kosilek v. Spencer

NeitherRelied on

U.S. District Court, D. Massachusetts · trial (bench trial findings / conclusions of law) · court opinion

Their role: court-appointed expert (Fed. R. Evid. 706), initially retained to opine on whether Dr. Schmidt's (DOC's) proposed treatment was within prudent professional standards

The district court, having appointed Dr. Levine under Rule 706, found his trial testimony -- in which he ultimately opined that a prudent professional would not deny Kosilek sex reassignment surgery -- credible, and relied on it in part to conclude that Dr. Schmidt's recommended alternative treatment did not meet prudent professional standards. The court noted Levine's initial report had rested on erroneous assumptions (that Kosilek had not had the required real-life experience and could not afford surgery) which he abandoned after clarification at trial.

“Dr. Levine’s credible testimony at trial also contributes to the court’s conclusion that Dr. Schmidt is not a prudent professional”

Kosilek v. Spencer, 2012(opens another site)

“Most significantly, Dr. Levine testified that he did not believe a prudent professional would deny Kosilek sex reassignment surgery.”

Kosilek v. Spencer, 2012(opens another site)

Source: Kosilek v. Spencer, 2012(opens another site)

2012

Soneeya v. Spencer

NeitherCredited in part

U.S. District Court, D. Massachusetts · trial (bench trial findings of fact) · court opinion

Their role: defense expert witness; also separately served (outside this litigation) as the DOC mental-health contractor MHM's paid Gender Identity Disorder (GID) consultant, in which capacity he had evaluated the plaintiff in 2008

The court found that Levine and plaintiff's expert Dr. Kaufman agreed the plaintiff had a genuine, consolidated female gender identity and that continuing hormone therapy was appropriate, but disagreed on whether she had met the Standards of Care's readiness/eligibility criteria for surgery and on the long-term benefits of sex reassignment surgery. The court noted Levine's most recent evaluation of the plaintiff was conducted solely for this litigation, and that his opinions (like Dr. Kaufman's) were prepared for litigation and did not guide the plaintiff's actual treatment decisions.

“Both Dr. Levine and Dr. Kaufman concur that plaintiff has a genuine, consolidated female gender identity”

Soneeya v. Spencer, 2012(opens another site)

“Levine and Kaufman reports were prepared for litigation purposes and didn’t guide treatment decisions for Ms. Soneeya”

Soneeya v. Spencer, 2012(opens another site)

Source: Soneeya v. Spencer, 2012(opens another site)

2014

Kosilek v. Spencer

Discounted, criticized or limitedLimited

U.S. Court of Appeals for the First Circuit (en banc) · appeal (en banc, reversing grant of injunctive relief) · court opinion

Their role: court-appointed expert (Fed. R. Evid. 706)

The en banc majority recounted that Levine's position changed during his testimony -- he initially found Dr. Schmidt's view reasonable, then, after being reminded the court had ordered him to evaluate Kosilek as a free person, concluded surgery should not be denied -- and for that reason declined to count him among the experts supportive of Dr. Schmidt. The majority nonetheless held that even disregarding Levine's opinion entirely, the record otherwise supported the district court's finding that Dr. Schmidt's approach was not prudent.

“We do not list Dr. Levine among these providers because, as the reader will recall, there was some change in his testimony.”

Kosilek v. Spencer, 2014(opens another site)

“even were we to disregard Dr. Levine's opinion entirely, there was ample evidentiary support for the court’s conclusion that Dr. Schmidt’s approach was not prudent”

Kosilek v. Spencer, 2014(opens another site)

Source: Kosilek v. Spencer, 2014(opens another site)

2014

Kosilek v. Spencer

NeitherCited in a separate opinionlow confidence

U.S. Court of Appeals for the First Circuit (en banc) · appeal (en banc) -- authorship of this passage within the opinion is not clear from the chunk (first-person singular "I do not list..." suggests a separate concurring/dissenting writing rather than the per curiam majority voice) · court opinion

Their role: court-appointed expert (Fed. R. Evid. 706)

A separate opinion in the en banc decision (it writes in the first person, so it is not the majority's) says he ultimately testified that a prudent professional would not deny surgery, and for that reason does not count him among the prison doctor's critics or supporters.

“Considering this incongruity, I do not list Dr. Levine as one of Dr. Schmidt’s critics.”

Kosilek v. Spencer, 2014(opens another site)

Source: Kosilek v. Spencer, 2014(opens another site)

2015

Norsworthy v. Beard

Discounted, criticized or limitedGiven little weight

U.S. District Court, N.D. California · preliminary injunction · court opinion

Their role: expert retained by defendants (California Dept. of Corrections and Rehabilitation)

The court declined to strike his report but gave it very little weight in granting a preliminary injunction. It found the report misrepresented the WPATH Standards of Care, relied on generalizations about incarcerated people rather than an assessment of the plaintiff, contained illogical inferences, and cited an inmate who had supposedly received surgery in California custody when, as he later confirmed, none ever had.

“The Court gives very little weight to the opinions of Levine, whose report misrepresents the Standards of Care; overwhelmingly relies on generalizations about gender dysphoric prisoners, rather than an individualized assessment of Norsworthy; contains illogical inferences; and admittedly includes references to a fabricated anecdote.”

Norsworthy v. Beard, 2015(opens another site)

“But, as Levine has now confirmed, no CDCR inmate has ever received SRS.”

Norsworthy v. Beard, 2015(opens another site)

“these serious weaknesses in Levine’s report undermine his credibility as an expert”

Norsworthy v. Beard, 2015(opens another site)

Source: Norsworthy v. Beard, 2015(opens another site)

2018

Edmo v. Idaho Dep't of Corr.

Discounted, criticized or limitedGiven little weight

U.S. District Court, D. Idaho · trial (findings of fact after bench trial) · court opinion

Their role: retained by a contracted prison-medical vendor (Corizon) to lead a training on medical necessity of gender confirmation surgery for incarcerated patients; also cited as having been retained as a defense expert in Norsworthy v. Beard

The court found Levine an outlier in the field of gender dysphoria who does not ascribe to the WPATH Standards of Care and whose training materials do not reflect generally accepted opinions in the field. Citing Norsworthy v. Beard, the court noted that another federal court had already given his opinion virtually no weight, and it gave virtually no weight to the opinions of defense experts whose views traced back to Levine's training and the guidelines it shaped.

“Dr. Levine is considered an outlier in the field of gender dysphoria and does not ascribe to the WPATH Standards of Care.”

Edmo v. Idaho Dep't of Corr., 2018(opens another site)

“the Court gives virtually no weight to the opinions of Defendants' experts”

Edmo v. Idaho Dep't of Corr., 2018(opens another site)

Source: Edmo v. Idaho Dep't of Corr., 2018(opens another site)

2018

Keohane v. Jones

Credited against the side that called themRelied on

U.S. District Court, N.D. Florida · trial (bench trial order granting relief) · court order

Their role: defendant's own retained expert witness

In an unusual posture, the court found the defendant's own expert Dr. Levine credible and relied heavily on his trial testimony -- that allowing the plaintiff to socially transition (grooming, clothing, undergarments) would be psychologically helpful/compassionate and that failing to treat gender dysphoria is destructive -- to rule for the plaintiff and against the prison, notwithstanding that Levine was called by the defense.

“In Dr. Levine’s opinion, “it’s destructive to ignore this mental complaint of gender dysphoria.””

Keohane v. Jones: Order

“Even Defendant’s own expert, Dr. Levine, agrees that allowing Ms. Keohane to dress and groom as a woman would be “psychologically helpful” in treating her gender dysphoria.”

Keohane v. Jones: Order

Source: Keohane v. Jones: Order

2019

Adree Edmo v. Corizon, Inc.

NeitherDescribed, not weighed

U.S. Court of Appeals for the Ninth Circuit · appeal (affirming preliminary injunction) · court opinion

Their role: court-appointed expert in the earlier Kosilek litigation, discussed here only as precedent

Rejecting the Fifth Circuit's broader reading of Kosilek in Gibson v. Collier, the Ninth Circuit clarified that Dr. Schmidt's and Dr. Levine's Kosilek testimony -- that surgery was not necessary for Kosilek specifically -- did not support a categorical rule that gender confirmation surgery is never medically necessary for any inmate.

“Dr. Schmidt and Dr. Levine testified that GCS was not necessary in the factual circumstances of that case”

Adree Edmo v. Corizon, Inc., 2019(opens another site)

Source: Adree Edmo v. Corizon, Inc., 2019(opens another site)

2019

Scott Gibson v. Bryan Collier

Helped the side that called themRelied on

U.S. Court of Appeals for the Fifth Circuit · appeal · court opinion

Their role: court-appointed expert in Kosilek (discussed as persuasive precedent), co-author of the WPATH Standards of Care 5th edition

The Fifth Circuit relied on the First Circuit's account of Kosilek, including Dr. Levine's testimony that later WPATH Standards of Care revisions were driven by political/advocacy considerations rather than medical judgment and that prudent professionals can reasonably differ over adequate gender-dysphoria treatment, to support its own holding that no Eighth Amendment violation occurs where genuine debate exists in the medical community.

“Dr. Levine ultimately agreed with Dr. Schmidt’s testimony”

Scott Gibson v. Bryan Collier, 2019(opens another site)

“Dr. Levine had helped to author the fifth version of the [WPATH] Standards of Care”

Scott Gibson v. Bryan Collier, 2019(opens another site)

Source: Scott Gibson v. Bryan Collier, 2019(opens another site)

2020

Hecox v. Little

Discounted, criticized or limitedGiven little weight

U.S. District Court, D. Idaho · preliminary injunction · court order

Their role: expert relied on by intervenor-defendants for the proposition that policies allowing transgender women to compete on women's teams are harmful to transgender individuals

The court noted that another judge of the same district (in Edmo) had already determined Levine is an outlier in the field and placed virtually no weight on his opinion, and cited Norsworthy v. Beard's criticism of his report; the court accepted plaintiff's evidence instead and granted the preliminary injunction.

“another judge of this Court previously determined that Dr. Levine is an outlier in the field of gender dysphoria and placed “virtually no weight” on his opinion”

Hecox v. Little: Order on Motion for Preliminary Injunction

Source: Hecox v. Little: Order on Motion for Preliminary Injunction

2021

Hennessy-Waller v. Snyder

Helped the side that called themRelied onmedium confidence

U.S. District Court, D. Arizona · preliminary injunction · court order

Their role: defendant's retained expert (declaration)

The court denied a preliminary injunction, relying in part on "the conflicting opinions provided by well-qualified experts" -- including Levine's declaration opposing coverage of gender-confirmation surgery for a minor -- together with the lack of evidence the plaintiffs had been evaluated by a psychologist or psychiatrist, to find the merits of the EPSDT Medicaid claim doubtful.

“the conflicting opinions provided by well- qualified experts and the lack of any evidence showing Plaintiffs have been evaluated by a psychologist or psychiatrist, the Court finds Plaintiffs have not clearly shown the surgery is medically necessary”

Hennessy-Waller v. Snyder: Order on Motion for Preliminary Injunction

Source: Hennessy-Waller v. Snyder: Order on Motion for Preliminary Injunction

2023

DOE v. LADAPO

Credited against the side that called themCredited in part

U.S. District Court, N.D. Florida · preliminary injunction · court order

Their role: defendants' retained expert

The court singled Levine out as the only defense expert who had actually treated a significant number of transgender patients and found he addressed the issues conscientiously rather than as a biased advocate. The court credited his concession that gender-affirming hormone treatment is sometimes appropriate and used his proposed safeguards as a benchmark, while declining to adopt his broader skepticism of the standards of care (crediting instead the testimony of plaintiffs' experts on that score).

“That expert is Dr. Stephen B. Levine, the only defense expert who has actually treated a significant number of transgender patients. He addressed the issues conscientiously, on the merits, rather than as a biased advocate.”

DOE v. LADAPO: Order on Motion for Preliminary Injunction

“Even the defendants’ expert Dr. Levine testified that treatment with GnRH agonists and cross-sex hormones is sometimes appropriate.”

DOE v. LADAPO: Order on Motion for Preliminary Injunction

Source: DOE v. LADAPO: Order on Motion for Preliminary Injunction

2023

Dekker v. Weida

Credited against the side that called themCredited in part

U.S. District Court, N.D. Florida · trial (order on the merits) · court opinion

Their role: defendants' retained expert

In this earlier companion case (Levine's "first appearance" per the later DOE v. LADAPO opinion), the court found Levine, the only defense expert who had actually treated a significant number of transgender patients, addressed the issues conscientiously rather than as a biased advocate, and credited his testimony that cross-sex hormones are sometimes appropriate and that treatment should not be banned outright, while ruling for the plaintiffs.

“He addressed the issues conscientiously, on the merits, rather than as a biased advocate.”

Dekker v. Weida: Order

“These plaintiffs qualify for treatment under Dr. Levine’s proposed safeguards.”

Dekker v. Weida: Order

Source: Dekker v. Weida: Order

2023

Dylan Brandt v. Tim Griffin

Credited against the side that called themCredited in part

U.S. District Court, E.D. Arkansas · trial (findings of fact and conclusions of law, permanent injunction) · court opinion

Their role: the State's retained expert (the only state expert with experience treating gender-dysphoria patients)

The court found Levine "a very credible witness" struggling with a conflict between his scientific understanding and his faith, and relied on his own testimony that abruptly cutting off gender-affirming care already in progress would be "shocking" and "devastating" to support the ruling for plaintiffs. But the court declined to credit his (and Dr. Hruz's) opinion that there was insufficient evidence of efficacy, and separately found his testimony on desistance/regret "inconsistent and unreliable," preferring plaintiffs' experts on those points. The court struck down Arkansas's ban (Act 626).

“The Court found Dr. Levine a very credible witness who struggles with the conflict between his scientific understanding for the need for transgender care and his faith.”

Dylan Brandt v. Tim Griffin: Originating court document filed consisting of notice of appeal, Findings of Fac

“The State’s expert, Dr. Levine, described the psychological impact of cutting off gender- affirming medical care for those currently receiving it as “shocking” and “devastating.””

Dylan Brandt v. Tim Griffin: Originating court document filed consisting of notice of appeal, Findings of Fac

“The Court found Dr. Levine’s testimony to be inconsistent and unreliable in this area.”

Dylan Brandt v. Tim Griffin: Originating court document filed consisting of notice of appeal, Findings of Fac

“The Court does not credit these opinions”

Dylan Brandt v. Tim Griffin: Originating court document filed consisting of notice of appeal, Findings of Fac

Source: Dylan Brandt v. Tim Griffin: Originating court document filed consisting of notice of appeal, Findings of Fac

2023

L. W. v. Jonathan Skrmetti

Discounted, criticized or limitedGiven little weight

U.S. District Court, M.D. Tennessee · preliminary injunction · court opinion

Their role: defendants' retained expert

The court found Levine's testimony on several specific risk claims (diminished sexual response, bone density, cardiovascular disease) unpersuasive and undermined by illogical inferences, noting he cited no studies for some claims and that his opinions on similar topics had already been treated with skepticism by other courts (citing Edmo and Norsworthy). The court credited plaintiffs' expert instead and granted the preliminary injunction in relevant part.

“The Court also notes that the testimony of both Dr. Laidlaw and Dr. Levine, on topics virtually identical to those on which they testify on behalf of Defendants in this case, has been treated by courts with a dose of skepticism.”

L. W. v. Jonathan Skrmetti: MEMORANDUM OPINION

“The Court also notes that it is not alone in observing that Dr. Levine’s testimony includes illogical inferences that undermine his conclusions.”

L. W. v. Jonathan Skrmetti: MEMORANDUM OPINION

“the Court does not find Dr. Levine’s testimony on this subject persuasive, particularly in light of the conclusions contained in the guidelines that contradict his findings.”

L. W. v. Jonathan Skrmetti: MEMORANDUM OPINION

Source: L. W. v. Jonathan Skrmetti: MEMORANDUM OPINION

2024

DOE v. LADAPO

Credited against the side that called themCredited in part

U.S. District Court, N.D. Florida · trial (order/opinion on the merits, permanent injunction) · court opinion

Their role: defendants' retained expert (testified previously in the related Dekker v. Weida trial, and again in this case)

The court again described Levine as the only defense expert to have treated a significant number of transgender patients, and as having conscientiously addressed the issues in his first (Dekker) appearance; it found him "not as forthcoming" in his second appearance in this trial, though he stood by his prior testimony and again acknowledged gender-affirming care is sometimes appropriate. The court cited his suggested prerequisites/safeguards as a plausible model the legislature could have adopted instead of a categorical ban, while ultimately ruling for the plaintiffs and against the state's broader ban.

“He was not as forthcoming in his second appearance—in the trial of this case—but he explicitly stood by his prior testimony”

DOE v. LADAPO: ORDER ON THE MERITS

“The Legislature or Boards could have established prerequisites to gender-affirming care, perhaps like those suggested by Dr. Levine.”

DOE v. LADAPO: ORDER ON THE MERITS

Source: DOE v. LADAPO: ORDER ON THE MERITS

2024

Maxwell Kadel v. Dale Folwell (consolidated with Shauntae Anderson v. William Crouch)

NeitherAdmitted over objection

U.S. Court of Appeals for the Fourth Circuit (en banc) · appeal -- summarizing the district court's admissibility ruling · court opinion

Their role: defendants' retained expert (physician and professor of psychiatry)

The en banc court recounted that the district court (in the underlying Kadel proceedings) had found Dr. Levine qualified to testify as a mental-health provider on matters within his professional purview, while excluding certain other testimony from other experts outside their expertise.

“It also found that Dr. Stephen Levine, a physician and professor of psychiatry, was qualified as a mental health provider”

Shauntae Anderson v. William Crouch: Published authored opinion filed

Source: Shauntae Anderson v. William Crouch: Published authored opinion filed

2024

Maxwell Kadel v. Dale Folwell (consolidated with Shauntae Anderson v. William Crouch)

Discounted, criticized or limitedCriticized

U.S. Court of Appeals for the Fourth Circuit (en banc) · appeal (majority opinion) · court opinion

Their role: defense expert whose declaration appellants (the states) cited for the proposition that no reliable studies show the treatments improve patient wellbeing

The majority rejected the states' argument -- grounded on Stephen B. Levine's declaration -- that no reliable studies support the challenged treatments, calling the argument "unpersuasive" and instead anchoring its discussion of accepted facts in an amicus brief from medical organizations.

“citing J.A. 3698, n.3, Declaration of defense expert Stephen B. Levine”

Shauntae Anderson v. William Crouch: Published authored opinion filed

“This argument is unpersuasive.”

Shauntae Anderson v. William Crouch: Published authored opinion filed

Source: Shauntae Anderson v. William Crouch: Published authored opinion filed

2024

Maxwell Kadel v. Dale Folwell (consolidated with Shauntae Anderson v. William Crouch)

NeitherCited in a separate opinion

U.S. Court of Appeals for the Fourth Circuit (en banc) · appeal -- DISSENT (Judge Richardson, joined by Judges Wilkinson, Niemeyer, and others; this is not the court's holding) · court opinion

Their role: defense expert whose expert disclosure report is cited as evidence of a genuine, ongoing medical/scientific dispute over the necessity and efficacy of gender-dysphoria treatments

The principal dissent cited Dr. Stephen B. Levine's expert disclosure report (alongside Dr. Paul Hruz's declaration) as evidence that a genuine medical dispute exists over the necessity and efficacy of gender-dysphoria treatments, arguing this supplies a legitimate, nondiscriminatory basis for the challenged coverage exclusions -- a position the en banc majority did not adopt.

“See Anderson, J.A. 1860–1935 (Expert Disclosure Report of Dr. Stephen B. Levine, M.D)”

Shauntae Anderson v. William Crouch: Published authored opinion filed

“it cannot be said that the plans obviously use gender dysphoria to discriminate by proxy against transgender persons”

Shauntae Anderson v. William Crouch: Published authored opinion filed

Source: Shauntae Anderson v. William Crouch: Published authored opinion filed

2025

Clark v. Valletta

Helped the side that called themRelied on

U.S. Court of Appeals for the Second Circuit · appeal (qualified immunity / summary judgment) · court opinion

Their role: defendants' expert (report and deposition)

Reversing the district court's denial of qualified immunity, the Second Circuit relied on Levine's report -- describing "considerable growing disagreement within the medical and scientific communities" about treating gender dysphoria, and his deposition testimony that the plaintiff's treatment was "far less than ideal" but tempered by prison-culture context -- to hold that a genuine medical debate existed and that the defendants' course of treatment was not objectively unreasonable.

“considerable growing disagreement within the medical and scientific communities on how to best treat people with gender”

Clark v. Valletta, 2025(opens another site)

“Levine testified that Clark’s treatment was “far less than ideal.””

Clark v. Valletta, 2025(opens another site)

“Levine tempered that assessment with an acknowledgment of “prison life and prison culture””

Clark v. Valletta, 2025(opens another site)

Source: Clark v. Valletta, 2025(opens another site)

L.B. v. Premera Blue Cross

NeitherDescribed, not weighed

U.S. District Court (Western District of Washington, per docket context) · class certification · court order

Their role: one of several experts whose reports the insurer submitted regarding medical necessity

In the course of ruling on a motion to certify a class, the court's order lists Dr. Stephen Levine, M.D. among several experts (Ayad, Burgo, Anderson, Mason, Montante) whose reports the insurer submitted; the order does not itself evaluate the weight or credibility of Levine's opinions.

“Reports of Sasha Ayad, Joseph Burgo, Ph.D., Erica Anderson, Ph.D., Stephen Levine, M.D., Julia Mason, M.D., and Steven Montante, M.D.”

L.B. v. Premera Blue Cross: Order on Motion to Certify Class

Source: L.B. v. Premera Blue Cross: Order on Motion to Certify Class

Cited as an author, not a witness

Not in the archive: Several opinions in this corpus describe or rely on rulings that are not themselves in these files: (1) Edmo v. Idaho Dep't of Corr. (D. Idaho 2018) and Hecox v. Little (D. Idaho 2020) both describe/cite a prior ruling in Norsworthy v. Beard giving Levine's opinion little/no weight -- the full Norsworthy opinion IS present here, so this is not actually missing, but note the daisy-chain of courts citing each other's Levine findings (Norsworthy -> Edmo -> Hecox -> L.W. v. Skrmetti all cite each other on Levine). (2) The Second Circuit's opinion in Clark v. Valletta quotes the district court's own ruling ("the district court concluded that 'no reasonable official would have believed...'") but the underlying district court opinion/order itself is not among these files, only the Second Circuit's characterization of it. (3) The Fourth Circuit's en banc opinion in Kadel v. Folwell / Anderson v. Crouch describes the underlying district court's Daubert-type qualification ruling on Levine and the district court record citations (J.A. cites), but the underlying W.D.N.C./S.D.W.Va. district court opinions themselves are not in this corpus. (4) Hecox v. Little's later Ninth Circuit appellate history (if any addressed Levine specifically) is not in this corpus -- only the district court's 2020 preliminary-injunction order is included. (5) The Kosilek v. Spencer chunk at rid 70386 ("I do not list Dr. Levine as one of Dr. Schmidt's critics") is written in the first-person singular, suggesting it comes from a concurring or dissenting opinion in the 2014 en banc decision (the docket shows separate writings by Judge Torruella (majority), Chief Judge Thompson, and others) -- the chunking in this corpus does not identify which judge's opinion this passage belongs to, so its precedential weight (majority vs. separate writing) could not be confirmed from the text alone.

Cases and roles

CaseYearsArenaRetained byWhat they filed
Dekker v. Weida
U.S. District Court, N.D. Florida (Tallahassee Division), Case No. 4:22-cv-00325-RH-MAF
2022-2023insurance / Medicaid (Florida Medicaid gender-affirming-care exclusion)Defendants (Florida Medicaid officials, incl. Jason Weida, Secretary of the Agency for Health Care Administration) Exhibit Ex 12 Dr. Levine Expert ReportExhibit Exhibit A-Expert Witness Report of Stephen B. LevineExhibit Exhibit Q- Rebuttal Report of Stephen B. Levine M.D.Motion in LimineMemorandum in Support of MotionExhibit 83 - Deposition of Stephen Levine, B.P.J. v. W. VAExhibit 85 - Deposition of Stephen Levine, Claire v. D.M.S.Exhibit 86 - Deposition of Stephen Levine, Fain v. Crouch
+2 moreExhibit 87 - Deposition of Stephen Levine, Kadel v. FolwellExhibit 275 - Email exchange between Andrew Sheeran and Romi...
Hennessy-Waller v. Snyder
U.S. District Court, D. Arizona, Case No. 4:20-cv-00335-SHR
2020-2021insurance / Medicaid (Arizona AHCCCS coverage exclusion for adolescents)Defendant (Jami Snyder, Director of the Arizona Health Care Cost Containment System) Expert Declaration of Dr. Stephen B. Levine, M.D.Response in Opposition to MotionSubpoena to Produce DocumentsSubpoena to Produce Documents
Keohane v. Jones
U.S. District Court, N.D. Florida (Tallahassee Division), Case No. 4:16cv511-MW/CAS
2016-2018 (his deposition May 2017)prisonDefendants (Julie Jones, Secretary, Florida Dept. of Corrections; Teresita Dieguez, Director, Everglades Correctional Institution) Exhibit J - Levine DepoNOTICE of Filing Exhibits in support of Response to MotionEmergency Motion for Temporary Restraining OrderNOTICE of Filing Exhibits in support of Response to Motion
Norsworthy v. Beard
U.S. District Court, N.D. California (Judge Jon S. Tigar), preliminary-injunction order
2015prisonDefendants (California Dept. of Corrections and Rehabilitation) Order granting preliminary injunction, quoting and discussing (and ultimately r…
Maxwell Kadel v. Dale Folwell
U.S. District Court (M.D.N.C.) / U.S. Court of Appeals for the Fourth Circuit (en banc, 2024), No. 22-1721
2021-2024insurance (state employee health plan exclusion)Appellants/Defendants (North Carolina State Health Plan; Dale Folwell, State Treasurer) Joint Appendix (Dale Folwell and Dee Jones)Joint Appendix (Dale Folwell and Dee Jones)Joint Appendix Vol. 1Joint Appendix Vol. 2Joint Appendix Vol. 3Joint Appendix Vol. 4Joint Appendix Vol. 5Joint Appendix Vol. 6
+1 moreJoint Appendix Vol. 7
Shauntae Anderson v. William Crouch
U.S. District Court (S.D. W. Va.) / U.S. Court of Appeals for the Fourth Circuit, No. 22-1927
2022-2026insurance / Medicaid (West Virginia Medicaid gender-affirming-surgery exclusion)Defendant (William Crouch, Secretary, West Virginia Dept. of Health and Human Resources) -- consistent with the 'Fain v. Crouch' deposition of Dr. Levine reused as an exhibit in Dekker Joint Appendix Vol. 1Joint Appendix Vol. 2Joint Appendix Vol. 3Joint Appendix Vol. 4Joint Appendix Vol. 5
DOE v. LADAPO
U.S. District Court, N.D. Florida, Case No. 4:23cv114-RH-MAF (trial-merits order)
2023-2024youth care ban (Florida SB254/rules restricting gender-affirming care for minors)Defendants (Florida Surgeon General Joseph Ladapo and state medical boards) -- inferred from the order's description of 'Dr. Levine' proposing prerequisites the defense's rulemaking could have adopted; not independently confirmed in a document authored by Levine Response in Opposition to MotionResponse in Opposition to Motion
Hecox v. Little
not established in the collected documents (widely reported as the Idaho federal challenge to the state's transgender-athlete ban)
2020sportsnot established in the collected documents; likely the State of Idaho given the case posture, but no Levine-authored text in this corpus confirms it Exhibit B- Expert Affidavit of Dr. Stephen LevineSupplement
B.P.J. v. West Virginia State Board of Education
not established in the collected documents (the West Virginia trans-athlete/school-sports case)
2023-2024sports / school policynot established in the collected documents Motion by B.P.J. and Heather Jackson for stay pending appealIndex to Appendix

Also named in these cases' filings, though the archive holds no testimony of their attributed to them: L.E. v. Lee; John and Jane Parents 1 v. Montgomery County Board of Education; January Littlejohn v. School Board of Leon County Florida.

Typical stance

Psychotherapy before physical intervention

Levine argues that gender dysphoria in children and adolescents should first be explored in psychotherapy for underlying causes (trauma, family dynamics, peer influence, other mental illness) rather than met with immediate social or medical affirmation, and that this exploratory approach can itself change outcomes.

“there is no evidence beyond anecdotal reports that psychotherapy can enable a return to male identification for genetically male boys, adolescents, and men”

Hennessy-Waller v. Snyder: Exhibit B

“This often involves a focus on disruptions in their attachment to parents in vulnerable children”

Dekker v. Weida: Exhibit Ex 12 Dr. Levine Expert Report

“I believe the surgeon needs to have an understanding of the person. I don't have an understanding whatsoever of the techniques of surgery. You see? I am just a psychiatrist.”

Seen in: Hennessy-Waller v. Snyder, Dekker v. Weida, Claire v. D.M.S.

Most childhood dysphoria desists

Levine's central clinical claim is that the large majority of children who present with gender dysphoria will 'desist' -- stop identifying as transgender -- by adulthood if not socially or medically transitioned, and that social transition and puberty blockers themselves sharply reduce desistance rates.

“majority of children who present with gender dysphoria will desist from desiring a transgender identity by adulthood if left untreated”

Hennessy-Waller v. Snyder: Exhibit B

“Social transition of young children is a powerful psychotherapeutic intervention that radically changes outcomes, almost eliminating desistance”

Dekker v. Weida: Exhibit Ex 12 Dr. Levine Expert Report

“I would consider banning puberty blocking hormones even for children who have been cross-gender identified for four years to give them a chance to desist, which is exactly what the Dutch protocol did, by the way.”

Seen in: Hennessy-Waller v. Snyder, Dekker v. Weida, Kadel v. Folwell

Evidence for youth transition is low quality

Levine argues the scientific evidence supporting puberty blockers, cross-sex hormones, and surgery for minors is of very low quality by GRADE standards, pointing to the Cochrane Library, NICE/Cass evidence reviews, and the Endocrine Society's own admissions, and that the field confuses opinion with knowledge.

“It is important for all sides to admit that the knowledge base concerning the causes and treatment of gender dysphoria has low scientific quality”

Dekker v. Weida: Exhibit Ex 12 Dr. Levine Expert Report

“commissioned an evidence review concerning the efficacy and safety of hormonal treatments now commonly administered to”

Dekker v. Weida: Exhibit Ex 12 Dr. Levine Expert Report

“Unfortunately, in this field opinion is too often confused with knowledge, rather than clearly locating what exactly is scientifically known.”

Hennessy-Waller v. Snyder: Exhibit B

Seen in: Hennessy-Waller v. Snyder, Dekker v. Weida

Comorbid conditions drive gender distress

Levine emphasizes that children and adolescents presenting with gender dysphoria have very high rates of other mental-health conditions (autism, ADHD, trauma, depression) and disproportionately come from vulnerable groups, and argues these comorbidities -- not an innate cross-sex identity -- often explain the distress.

“children on the autistic spectrum (at a rate more than 7x the general population)”

Dekker v. Weida: Exhibit Ex 12 Dr. Levine Expert Report

“It is undisputed that children and adolescents who present with gender dysphoria exhibit a very high level of mental health comorbidities”

Dekker v. Weida: Exhibit Ex 12 Dr. Levine Expert Report

“Their gender dysphoria may be a product, you see, of these other things.”

Seen in: Dekker v. Weida, Kadel v. Folwell

Informed consent requires disclosing uncertainty

Levine argues true informed consent means telling patients and parents what is actually known and unknown about outcomes, rather than what clinicians believe or hope, and criticizes framing (e.g., suicide-risk statistics) that he says exaggerates certainty to justify affirmation-model care.

“Informed consent requires clinicians to tell the truth and ensure that their patients understand the truth”

Dekker v. Weida: Exhibit Ex 12 Dr. Levine Expert Report

“Informed consent does not mean sharing with the parents and patients what the doctor believes: it means sharing what is known and what is not known about the intervention”

Dekker v. Weida: Exhibit Ex 12 Dr. Levine Expert Report

Seen in: Dekker v. Weida

Detransition and regret are under-documented

Levine contends that detransition and regret after transition occur more often than the affirmation-model literature acknowledges, though under cross-examination he has agreed that specific studies he cites do not measure detransition rates or trends.

“Regret following transition is not an infrequent phenomenon”

Hennessy-Waller v. Snyder: Exhibit B

“many effects of cross-sex hormones cannot be reversed should the patient later regret his transition”

Hennessy-Waller v. Snyder: Exhibit B

“But it doesn't mean that -- I think you're missing the point. And, and by, by having me say yes, that it doesn't quantify the incidents of detransition, it's missing the point.”

Seen in: Hennessy-Waller v. Snyder, Fain v. Crouch

WPATH is an advocacy organization, not a pure science body

Levine, a former WPATH Standards of Care chair, argues the organization abandoned scientific rigor for activism after his tenure, and that its Standards of Care reflect political/advocacy commitments rather than settled evidence.

“I resigned my membership in 2002 due to my regretful conclusion that the organization and its recommendations had become dominated by politics and ideology, rather than by scientific process”

Hennessy-Waller v. Snyder: Exhibit B

“WPATH explicitly views itself as not merely a scientific organization, but also as an advocacy organization”

Dekker v. Weida: Exhibit Ex 12 Dr. Levine Expert Report

“The limitations of the Standards of Care, however, are not primarily political”

Hennessy-Waller v. Snyder: Exhibit B

Seen in: Hennessy-Waller v. Snyder, Dekker v. Weida

SRS in prison is elective, not urgent

In prison litigation, Levine argued sex reassignment surgery is always an elective procedure with no medical urgency, that gender dysphoria is not comparable to physical pain, and speculated that an inmate's female gender identity could be an adaptive response to incarceration that might change after release.

“SRS is always an elective procedure. There is no immediacy to it.”

Norsworthy v. Beard: opinion

“advocates exaggerate the suffering of gender dysphoria through a misunderstanding of its nature”

Norsworthy v. Beard: opinion

“transition to femaleness is an adaptive response to long term incarceration”

Norsworthy v. Beard: opinion

Seen in: Norsworthy v. Beard, Keohane v. Jones

"Medically necessary" is over-used and needs limits

Levine argues the phrase 'medically necessary' has been stretched to cover essentially any request a transgender patient makes (hairstyles, cosmetic procedures), and that he draws his own line at interventions with a physiological basis (hormones, surgery) while treating grooming/clothing requests as merely psychologically beneficial, not medically necessary.

“Everything a person wants is called medically necessary. And in that light, you know, we reduce this matter to absurdity.”

Keohane v. Jones: NOTICE of Filing Exhibits in support of Response to Motion f

“I've been trained for many years not to use the word never.”

Keohane v. Jones: NOTICE of Filing Exhibits in support of Response to Motion f

“hormone therapy could be medically necessary for a patient, sex reassignment surgery could be medically necessary for a particular patient”

Keohane v. Jones: NOTICE of Filing Exhibits in support of Response to Motion f

Seen in: Keohane v. Jones

How their positions have shifted

Levine chaired the WPATH (then Harry Benjamin International Gender Dysphoria Association) Standards of Care committee that produced the 5th edition in the 1990s, then resigned in 2002, describing the organization as having become 'dominated by politics and ideology' (100482). His 2015 Norsworthy declaration, in a prison case, focused narrowly on surgery as elective and not urgent, relying partly on an anecdote about an inmate's SRS that he later confirmed was false (105591). By his 2017 Keohane deposition he was elaborating a general framework distinguishing 'medically necessary' physiological interventions from psychologically beneficial but non-necessary accommodations (119875). His 2020 Hennessy-Waller declaration and 2023 Dekker v. Weida report (111960/112147) extend the same desistance/exploratory-therapy framework to pediatric gender medicine specifically, now buttressed by citations to the Cochrane Library, NICE evidence reviews, and the Cass Review that postdate his earlier prison-case testimony, and by then his reports and depositions (112149, 112150) show him explicitly framing his 2015-era views on 'medical necessity' as an earlier stage of his own 'continued evolution of thinking' (112150, ~2023 dep., discussing his 2015 statements).

Under cross-examination

Their own answers in depositions.

Personal clinical practice includes authorizing gender-affirming care · Kadel v. Folwell

“I have. I have not recently, because most of my patients are 13 or 15 or 16, you know.”

Scope of his opinion on plaintiffs' gender dysphoria diagnoses · Kadel v. Folwell

“Yes, correct.”

Qualifications regarding surgical technique · Claire v. D.M.S.

“I believe the surgeon needs to have an understanding of the person. I don't have an understanding whatsoever of the techniques of surgery. You see? I am just a psychiatrist.”

Limits of a study he cited on detransition · Fain v. Crouch

“But it doesn't mean that -- I think you're missing the point. And, and by, by having me say yes, that it doesn't quantify the incidents of detransition, it's missing the point.”

Adequacy of a study's comparison groups · Kadel v. Folwell

“That is correct. And may I add that it's very, very difficult to understand. The natural question would be, how do you compare the general population with the trans people who did not have surgery with the trans people who did have surgery.”

Whether some hormone/surgical care can be medically necessary · Keohane v. Jones

“hormone therapy could be medically necessary for a patient, sex reassignment surgery could be medically necessary for a particular patient”

Keohane v. Jones: NOTICE of Filing Exhibits in support of Response to Motion f
Refusal to say gender-affirming care is never appropriate · Keohane v. Jones

“I've been trained for many years not to use the word never.”

Keohane v. Jones: NOTICE of Filing Exhibits in support of Response to Motion f
Role as policy advocate versus clinician · Kadel v. Folwell

“look, I'm a doctor. I'm not a policy maker”

Testimony that travels

Sentences that appear word for word in their filings in different cases.

  • “WPATH explicitly views itself as not merely a scientific organization, but also as an advocacy organization.” in 3 documents: 100482, 111960, 112147
  • “The limitations of the Standards of Care, however, are not primarily political.” in 3 documents: 100482, 111960, 112147
  • “They are caused by the lack of rigorous research in the field, which allows room for passionate convictions on how to care for the transgendered.” in 3 documents: 100482, 111960, 112147
  • “Unfortunately, in this field opinion is too often confused with knowledge, rather than clearly locating what exactly is scientifically known.” in 3 documents: 100482, 111960, 112147
  • “Notably, gender dysphoria is the only psychiatric condition to be treated by surgery” in 3 documents: 100482, 111960, 112147
  • “From 1997 through 1998, I served as the Chairman of the eight-person International Standards of Care Committee that issued the fifth version of the Standards of Care” in 3 documents: 100482, 111960, 112147
  • “This often involves a focus on disruptions in their attachment to parents in vulnerable children, for instance, those in the foster care system.” in 3 documents: 100482, 111960, 112147

Curriculum vitae

Current positions

  • Clinical Professor of Psychiatry at Case Western Reserve University School of Medicine, with an active private clinical practice. source
    “I am Clinical Professor of Psychiatry at Case Western Reserve University School of Medicine, and maintain an active private clinical practice.”
  • Co-Director of the gender clinic he founded in 1974 (renamed and made independent of Case Western in 1993); still serving in that role as of the 2023 Dekker report. source
    “In 1974, I founded the Case Western Reserve University Gender Identity Clinic, and have served as Co-Director of that clinic since that time.”
  • Ongoing paid consultant to the Massachusetts Department of Corrections on transgender-inmate treatment, a role held since 2007. source
    “I have been retained by the Massachusetts Department of Corrections as a consultant on the treatment of transgender inmates since 2007.”

Education and training

  • BA, Washington and Jefferson College, 1963. source
    “1963 BA Washington and Jefferson College”
  • MD, Case Western Reserve University School of Medicine, 1967. source
    “1967 MD Case Western Reserve University School of Medicine”
  • Psychiatric residency, University Hospitals of Cleveland, 1970-73 (with a 1967-68 internal medicine internship and 1968-70 research post at NIAMD). source
    “1970-73 Psychiatric Residency, University Hospitals of Cleveland”
  • Board certified by the American Board of Neurology and Psychiatry, June 1976. source
    “Board Certification 6/76 American Board of Neurology and Psychiatry”

Past positions and roles

  • Assistant Professor of Psychiatry at Case Western Reserve, 1973; promoted to Associate Professor (1979), tenure (1982), and Full Professor (1985), before becoming Clinical Professor. source
    “1985- Full Professor”
  • Early member of the Harry Benjamin International Gender Dysphoria Association (later WPATH) and chairman of the 8-person committee that wrote the 5th version of its Standards of Care (1997-98). source
    “I was an early member of the Harry Benjamin International Gender Dysphoria Association (later known as WPATH) and served as the Chairman of the committee that developed the 5th version of its Standards of Care.”
  • Resigned WPATH membership in 2002, saying the organization had become an advocacy group rather than a neutral scientific body. source
    “I resigned my membership in 2002 due to my regretful conclusion that the organization and its”
  • Co-director of the Center for Marital and Sexual Health / Levine, Risen & Associates, Inc., Beachwood, Ohio, from 1992 until 2017. source
    “Co-director, Center for Marital and Sexual Health/ Levine, Risen k Associates, Inc. until”
  • Court-appointed independent expert for a federal judge (Mark Wolf, E.D. Mass.) in prison litigation over a transgender inmate; the First Circuit's 2014 en banc opinion cited and relied on his testimony. source
    “In 2006, Judge Mark Wolf of the Eastern District of Massachusetts asked me to serve as an independent, court-appointed expert in a litigation involving the treatment of a transgender inmate within the Massachusetts prison system.”
  • Consultant to the California Department of Corrections and Rehabilitation (2012-2015) and to the Virginia, New Jersey, and Idaho corrections departments on individual inmate evaluations. source
    “California Department of Corrections and Rehabilitation; 2012-2015; education, inmate”
  • President of the Society for Sex Therapy and Research, 1987-89. source
    “1987-89-President”

Clinical practice

  • Says he was the primary psychiatric caregiver for several dozen gender-clinic patients and supervised other therapists' work; the clinic saw 'hundreds' of transgender patients over the years, with children seen only occasionally. source
    “I was the primary psychiatric caregiver for several dozen of our patients and supervisor of the work of other therapists.”
  • Under cross-examination in his own deposition, he estimated he has personally treated gender-dysphoric children only rarely, and that most of his clinic's early-era patients were adults. source
    “I have only on a rare occasion personally”
  • His answer distinguishing personal treatment from supervisory oversight of colleagues who treated children. source
    “treated or directly or indirectly treated a child”
  • His answer confirming that in the clinic's early years (roughly 1974-1993), most patients were adults, not children or adolescents. source
    “you must understand most of the patients”
  • His estimate, given on cross-examination, that over his career he has probably seen only about six prepubertal children on a regular basis. source
    “probably only seen regularly six prepubertal children”
  • He agreed that during 1974-1993 the clinic's contact with children was infrequent, and confirmed his own prior deposition estimate of the prepubertal-child count was 'an estimate.' source
    “It's an estimate, yes.”
  • As a consultant to the Massachusetts prison system's gender-treatment team, he stated he had recently approved several letters authorizing bilateral mastectomies for incarcerated patients, though he had not personally written them. source
    “given my, my approval to several”

Publications and research

  • Author or co-author of more than 180 journal articles and book chapters, of which 27 deal with gender dysphoria (as of the 2023 Dekker report); five solo-authored books and senior editor of three editions of the Handbook of Clinical Sexuality for Mental Health Professionals. source
    “In total I have authored or co-authored over 180 journal articles and book chapters, 27 of which deal with the issue of gender dysphoria.”
  • Own gender-dysphoria publications he cites in his reports include: 'Reflections on the Legal Battles Over Prisoners with Gender Dysphoria' (2016), 'Ethical Concerns About Emerging Treatment Paradigms for Gender Dysphoria' (2017), 'Informed Consent for Transgender Patients' (2019), and 'Reflections on the Clinician's Role with Individuals Who Self-identify as Transgender' (2021). source
    “Levine, S. (2017). Ethical Concerns About Emerging Treatment Paradigms for”
  • States that the WPATH Standards of Care's limitations 'are not primarily political' but are 'caused by the lack of rigorous research in the field' -- i.e., he attributes disagreement in the field to an absence of solid outcome research rather than to politics alone. source
    “caused by the lack of rigorous research in the field, which allows room for passionate convictions”
  • In his own deposition he confirmed that none of the roughly 23 pharmaceutical-industry grants listed in his CV, nor his NIH lupus-and-sexuality grant, involved research on gender dysphoria treatment in adults, adolescents, or children. source
    “Were any of these 23 grants related to the”
  • He testified that he has never been part of a national or international body that published treatment guidelines for children/adolescents with gender dysphoria (apart from his role chairing the WPATH SOC-5 committee decades earlier), though a November 2021 article of his 'offered opinions about what the evaluation of adolescents and children ought to consist of.' source
    “in my November of”
  • Received a Robert Wood Johnson Foundation Clinical Scholar award (1974-77) and has been principal investigator on roughly 70 pharmacological-intervention studies for sexual dysfunction since 1989 -- none, per his deposition, on gender dysphoria. source
    “1974-77 Robert Wood Johnson Foundation Clinical Scholar”

Licenses, boards, honors

  • Licensed physician in Ohio (license no. Ohio 35-03-0234-L) and board certified by the American Board of Neurology and Psychiatry (June 1976). source
    “Board Certification 6/76 American Board of Neurology and Psychiatry”
  • Distinguished Life Fellow of the American Psychiatric Association (2005); fellow since 1971. source
    “I am a Distinguished Life Fellow of the American Psychiatric”
  • Masters and Johnson Lifetime Achievement Award, Society for Sex Therapy and Research, 2005. source
    “Masters and Johnson Lifetime Achievement Award from the Society of Sex Therapy and”
  • 2006 SSTAR Book Award (Exceptional Merit) for The Handbook of Clinical Sexuality for Mental Health Professionals; 2018 Albert Marquis Lifetime Achievement Award from Marquis Who's Who. source
    “2018 - Albert Marquis Lifetime Achievement Award”
  • Named to 'America's Top Doctors' consecutively since 2001; Case Western Department of Psychiatry Hall of Fame inductee, 2021. source
    “Named to America”

Disclosed compensation

  • Dekker v. Weida: $400.00 per hour source
  • Hennessy-Waller v. Snyder: $375/hour for preparation; $500/hour to prepare for and provide testimony source

Testimony they lists themselves

  • Michelle Kosilek v. Massachusetts Dept. of Corrections 2007 · trial (court-appointed witness for Judge Mark L. Wolf)
  • Massachusetts Dept. of Corrections defense of suit by prisoner Katheena Soneeya 2011, 2018-2019 · deposition and trial
  • State of Florida v. Reiyn Keohane 2017 · deposition/witness
  • Kadel et al. v. Folwell et al. (North Carolina) 2021 · deposition
  • Florida Department of Corrections (Everglades Correctional Institution) re: Reiyn Keohane 2017 · deposition, confirmed under cross-examination he was retained by FDOC and asked to opine on medical necessity of hair/underwear items

and 1 other matter they lists that are not in the litigation archive.

Sued as a defendant

Wittkowski v. Levine (Wittkowski v. Spencer) (U.S. District Court, D. Massachusetts · 2019). This is not a ruling on Levine's expert testimony -- it is a malpractice/deliberate-indifference suit in which Levine was a defendant. The court granted his (and the other defendant doctors') motion for summary judgment because the plaintiff had not disclosed a standard-of-care expert and could not otherwise establish medical malpractice. NOTE: identity caution -- the case caption uses the name "Steven"/"Stephen Levine"; the record's description of him as a psychiatrist retained to consult on the Massachusetts DOC's Gender Dysphoria Treatment Committee for MPCH parallels the description of Dr. Stephen B. Levine's known role as MHM's GID consultant in Soneeya v. Spencer (same Massachusetts prison system), and a co-pending Keohane v. Jones expert disclosure lists a case captioned "JoJo Witkowski vs. Steven Levine" among Dr. Stephen B. Levine's litigation history -- together indicating this is very likely the same Stephen B. Levine, not a different person of the same surname. order

Named at oral argument

Lawyers or judges mentioning them at argument; not rulings.

  • L. W. v. Jonathan Skrmetti (2023): Counsel for the state, during oral argument, characterized Dr. Levine's 1998-era testimony as supporting the state's position; this is an advocate's characterization, not a court finding. transcript(opens another site)
  • Jane Doe 1 v. William Thornbury, Jr. (2023): Counsel, during oral argument, described Dr. Levine as the one defense-side expert with relevant clinical experience and noted he opined a ban was inappropriate; an advocate's characterization, not a court finding. transcript(opens another site)
  • Tingley v. Ferguson (2022): Counsel for the petitioner, during oral argument, described Dr. Levine's and Dr. Rozic's expert reports as detailed and well-supported; an advocate's characterization, not a court finding. transcript(opens another site)
  • Kosilek v. Spencer (2014): Exchange between the bench and counsel at oral argument recounting the procedural history of the district court's use of Dr. Levine as a court-appointed expert; not itself a holding. transcript(opens another site)
  • Dylan Brandt v. Tim Griffin (2024): Appellee's counsel, at oral argument, invoked the district court's finding (see the Brandt ruling above) that even the state's own expert Dr. Levine testified the law's effects on adolescents already receiving care would be shocking and devastating, urging affirmance; an advocate's characterization of the trial record, not a new court holding. transcript(opens another site)

What the parties argued about them

Party filings, not rulings: motions, briefs and proposed findings.

  • Keohane v. Jones (2017): Defendant's Rule 26(a)(2) expert-witness disclosure attaching Dr. Levine's CV, prior report/deposition excerpts, and litigation history (including a reference to a case captioned "JoJo Witkowski vs. Steven Levine," i.e., the Wittkowski v. Levine malpractice suit against him in Massachusetts). This is a party submission, not a court ruling. filing
  • Keohane v. Jones (2017): Plaintiff's expert Dr. George R. Brown's rebuttal report responding to Dr. Levine's defense report. A party submission, not a court ruling. filing
  • Keohane v. Jones (2017): Plaintiff's proposed findings of fact cite Dr. Levine's deposition and report, including that he recommended and consults with the Massachusetts DOC's Gender Identity Disorder program (paralleling his consulting role described in Soneeya v. Spencer) and that he opined the plaintiff could face "acute decompensation" and suicidal crisis if denied requested access. A party submission, not a court ruling. filing
  • Hennessy-Waller v. Snyder (2021): Text of a [PROPOSED] order (drafted by a party, not confirmed here as entered/signed by the court) that would quash plaintiffs' subpoenas to Dr. Stephen Levine and Dr. Michael Laidlaw. filing

Sources and method

Built from the litigation archive: 123 excerpts of opinions and oral arguments and 31 court documents that name them, and 18 filings of their own. Every mention was checked for identity (29 mentions of other people with the same surname were set aside). Every quote on this page (109) was checked word for word against its source. Profile version 2. Gaps: Full first-person text (report/declaration/deposition) is available for only 5 of the 12 cases: Dekker v. Weida, Hennessy-Waller v. Snyder, Keohane v. Jones, Norsworthy v. Beard (which is actually the court's preliminary-injunction ORDER quoting his declaration, not the declaration itself -- his declaration is not in this corpus), and a deposition of his (112149) that was filed in Dekker but originated in 'Fain v. Crouch,' a West Virginia Medicaid case that may or may not be an earlier name for the same litigation as 'Shauntae Anderson v. William Crouch' -- the corpus does not confirm that identity. For Maxwell Kadel v. Folwell, Shauntae Anderson v. Crouch, and DOE v. LADAPO, retention/arena/court facts come only from appellate/trial opinions.json chunks that quote or describe his reports, not from his own words, so his own retained-by statement and compensation for those three cases are unknown. For Hecox v. Little, B.P.J. v. West Virginia State Board of Education, L.E. v. Lee, John and Jane Parents 1 v. Montgomery County Board of Education, and January Littlejohn v. School Board of Leon County Florida, the corpus holds only docket metadata (an affidavit/exhibit exists) with no extracted text of his own and no matching entry in opinions.json, so court, exact years, retaining party, and compensation for those five cases could not be established. No document in this corpus discusses his personal income from expert-witness work in aggregate, nor gives a rate for any case besides Dekker and Hennessy-Waller. His CV's 'Grant Support/Research Studies' list (~23 pharmaceutical-industry and NIH grants) contains no peer-reviewed outcome study of gender-dysphoria treatment that he ran himself; his own deposition confirms this absence, but the corpus does not otherwise show whether any peer-reviewed outcomes literature exists that he considers a fair test of his clinical approach.

Back to the anti-trans experts